GSK-J4, a Histone Demethylase JMJD3 Inhibitor, Modulates Immune-related Protein Expression on Colon Cancer Cells

Fangfang Li, Yunan Zhao, Zhongnan Yu, Gong Chen. GSK-J4, a Histone Demethylase JMJD3 Inhibitor, Modulates Immune-related Protein Expression on Colon Cancer Cells. In Weimiao Yu, Hui Sun, editors, BIBE 2020: The Fourth International Conference on Biological Information and Biomedical Engineering, Chengdu, China, July 21-23, 2020. ACM, 2020. [doi]

Abstract

Abstract is missing.